As of 2024-12-14, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (37.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -299.9%.
The range of the Relative Valuation is (28.32) - (49.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 35.0x | 25.8x |
| Forward P/E multiples | 19.2x - 33.3x | 25.7x |
| Fair Price | (28.32) - (49.04) | (37.98) |
| Upside | -249.1% - -358.1% | -299.9% |
| Date | P/E |